Stephan Schleim
Biographic Data
| ID | 6837205 |
|---|---|
| NAME | Stephan Schleim |
| GIVEN NAMES | Stephan |
| FAMILY NAME | Schleim |
| SIGNATURE | SCHLEIM S |
| AFFILIATIONS | University of Groningen |
| ORCID | 0000-0002-1041-3963 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Hirnforschung Und Mind Control: José M. R. Delgados «stimoceiver» im Vergleich zu Elon Musks Neuralink
Why mental disorders are brain disorders. And why they are not: ADHD and the challenges of heterogeneity and reification
Scientific attempts to identify biomarkers to reliably diagnose mental disorders have thus far been unsuccessful. This has inspired the Research Domain Criteria (RDoC) approach which decomposes mental disorders into behavioral, emotional, and cognitive domains. This perspective article argues that the search for biomarkers in psychiatry presupposes that the present mental health categories reflect certain (neuro-) biological features, that is, th…
Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology
Langlitz and colleagues wrote about clinically used psychedelic drugs and the possibility of a “moral psychopharmacology” earlier in this journal (1). They emphasized the context-dependency of the effects of these substances (e.g., ayahuasca, psilocybin) and the importance of understanding their impact on social and moral cognition, particularly now that there is more research on their possible clinical applications (e.g., to facilitate psychothe…
Neuroenhancement as Instrumental Drug Use: Putting the Debate in a Different Frame
The use of performance-enhancing drugs to study or work better is often called "cognitive enhancement" or "neuroenhancement" and sparked a debate between scholars from many disciplines. I argue that such behavior can better be subsumed under the more general category of "instrumental drug use". This broader perspective allows understanding neuroenhancement better from the perspective of addiction medicine and public health and supports a more con…
To Overcome Psychiatric Patients’ Mind–Brain Dualism, Reifying the Mind Won’t Help
OPINION article Front. Psychiatry, 30 June 2020 | https://doi.org/10.3389/fpsyt.2020.00605
How Empathy Became a Brain Function: A Neurophilosophical Case Study
Empathy is a topic of great relevance in current psychology, neuroscience, and related disciplines. Scholars recently emphasized the possible role of a lack of empathy in antisocial behavior associated with psychopathy. At the beginning of this paper, common conceptions of empathy, particularly cognitive and emotional empathy, as well as psychopathy are summarized. Subsequently, recent attempts to demonstrate empathic engagement in neuro-imaging …
Turning our attention to the neuroscience turn
Second thoughts on the prevalence of enhancement
No prominent works on this page.
Second thoughts on the prevalence of enhancement
Turning our attention to the neuroscience turn
How Empathy Became a Brain Function: A Neurophilosophical Case Study
Empathy is a topic of great relevance in current psychology, neuroscience, and related disciplines. Scholars recently emphasized the possible role of a lack of empathy in antisocial behavior associated with psychopathy. At the beginning of this paper, common conceptions of empathy, particularly cognitive and emotional empathy, as well as psychopathy are summarized. Subsequently, recent attempts to demonstrate empathic engagement in neuro-imaging …
Neuroenhancement as Instrumental Drug Use: Putting the Debate in a Different Frame
The use of performance-enhancing drugs to study or work better is often called "cognitive enhancement" or "neuroenhancement" and sparked a debate between scholars from many disciplines. I argue that such behavior can better be subsumed under the more general category of "instrumental drug use". This broader perspective allows understanding neuroenhancement better from the perspective of addiction medicine and public health and supports a more con…
To Overcome Psychiatric Patients’ Mind–Brain Dualism, Reifying the Mind Won’t Help
OPINION article Front. Psychiatry, 30 June 2020 | https://doi.org/10.3389/fpsyt.2020.00605
Why mental disorders are brain disorders. And why they are not: ADHD and the challenges of heterogeneity and reification
Scientific attempts to identify biomarkers to reliably diagnose mental disorders have thus far been unsuccessful. This has inspired the Research Domain Criteria (RDoC) approach which decomposes mental disorders into behavioral, emotional, and cognitive domains. This perspective article argues that the search for biomarkers in psychiatry presupposes that the present mental health categories reflect certain (neuro-) biological features, that is, th…
Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology
Langlitz and colleagues wrote about clinically used psychedelic drugs and the possibility of a “moral psychopharmacology” earlier in this journal (1). They emphasized the context-dependency of the effects of these substances (e.g., ayahuasca, psilocybin) and the importance of understanding their impact on social and moral cognition, particularly now that there is more research on their possible clinical applications (e.g., to facilitate psychothe…
Hirnforschung Und Mind Control: José M. R. Delgados «stimoceiver» im Vergleich zu Elon Musks Neuralink
Psychology (8 works) · Psychiatry (5 works) · Neuroethics, Human Enhancement, Biomedical Innovations (4 works) · Epistemology (3 works) · Medicine (3 works) · Mental Health and Psychiatry (3 works) · Neuroscience (3 works) · Attention Deficit Hyperactivity Disorder (2 works) · Biological Psychiatry (2 works) · Clinical Psychology (2 works)